Companies / BOC Sciences / Temelimab
BOC Sciences

Temelimab | BOC Sciences

(0) Write Review

Temelimab is an IgG4 monoclonal antibody that targets the human endogenous retroviral envelope protein HERV-W-Env. Temelimab has been investigated for the treatment of multiple sclerosis.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars